There are 27 resources available
The revolution of immunotherapy in endometrial cancer
Presenter: A. Oaknin, ES
Session: SESSION 3 - Treatment of recurrent-metastatic endometrial cancer – Part 1
Resources:
Slides
Webcast
Combinations of anti-PD-L1 and chemotherapy or TKI in endometrial cancer
Presenter: M. R. Mirza, DK
Session: SESSION 3 - Treatment of recurrent-metastatic endometrial cancer – Part 1
Resources:
Slides
Webcast
Predictive biomarkers in endometrial cancer
Presenter: D. Lorusso, IT
Session: SESSION 3 - Treatment of recurrent-metastatic endometrial cancer – Part 1
Resources:
Slides
Webcast
Participants clinical case discussion: Exceptional response to chemotherapy after immunotherapy
Presenter: M. Polignano, IT
Session: SESSION 3 - Treatment of recurrent-metastatic endometrial cancer – Part 1
Resources:
Slides
Webcast
Participants clinical case discussion: Endometrial carcinoma in a 71-year-old woman
Presenter: M. Le Moine, BE
Session: SESSION 3 - Treatment of recurrent-metastatic endometrial cancer – Part 1
Resources:
Slides
Webcast
Participants clinical case discussion: A case of endometrioid adenocarcinoma relapsing after 5 years, refractory to endocrine therapy and chemotherapy
Presenter: M. Zenatri, FR
Session: SESSION 3 - Treatment of recurrent-metastatic endometrial cancer – Part 1
Resources:
Slides
Webcast
PRO and QoL: How to manage
Presenter: J. E. Kurtz, FR
Session: SESSION 3 - Treatment of recurrent-metastatic endometrial cancer – Part 2
Resources:
Slides
Webcast
New agents on the horizon: ADC and beyond
Presenter: D. Lorusso, IT
Session: SESSION 3 - Treatment of recurrent-metastatic endometrial cancer – Part 2
Resources:
Slides
Webcast
Management of immune-related and TKI toxicities
Presenter: I. Colombo, CH
Session: SESSION 3 - Treatment of recurrent-metastatic endometrial cancer – Part 2
Resources:
Slides
Webcast
Participants clinical case discussion: A case of dMMR endometrial carcinoma with excellent response to second-line combination treatment
Presenter: G. Douganiotis, GR
Session: SESSION 3 - Treatment of recurrent-metastatic endometrial cancer – Part 2
Resources:
Slides
Webcast